# Deferasirox

NDC: 69539-022
Generic name: Deferasirox
Labeler / Manufacturer: MSN LABORATORIES PRIVATE LIMITED
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FOR SUSPENSION
Routes: ORAL
Marketing started: 20191120

FDA application: ANDA209878

## Active ingredients

- DEFERASIROX: 250 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69539-022"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69539-022
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e0726c9c-cee8-4fc1-abd1-68ad0db030dd